Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:
“MO138 in Biliary Cancer at ESMOAsia24 by Lorenza Rimassa.
ProvIDHe: phIIIb – Ivosidenib – mIDH1 (iCCA)
Awaited safety/activity – heavily pretreated (>ClarIDHy)
SOC NGS for IDH (=ClaIDHy (central))
ProvIDHE – 45
Spanish patients could access Ivosidenib.
Funding?”
More posts featuring Angela Lamarca.
